Clinical Trial

Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL

Name: Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL — clinical trial record (NCT07433400)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EVOLALPh1

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.

Trial Details

NCT Number	NCT07433400
Lead Sponsor	Group for Research in Adult Acute Lymphoblastic Leukemia
Conditions	Ph Positive ALL
Enrollment	500 participants
Start Date	2025-08-29
Primary Completion	2035-12-31 (estimated)
Study Completion	2035-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-25